Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
115 hedge funds and large institutions have $74M invested in Sanofi Contingent Value Rights in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 8 closing their positions.
3% less funds holding
Funds holding: 118 → 115 (-3)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
19% less capital invested
Capital invested by funds: $91.5M → $74M (-$17.4M)
22% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 18
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
+$6.02M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.05M |
| 3 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$699K |
| 4 |
LCM
Lonestar Capital Management
San Francisco,
California
|
+$365K |
| 5 |
JP Morgan Chase
New York
|
+$34.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6.22M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$5.92M |
| 3 |
PC
Pomelo Capital
New York
|
-$559K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$260K |
| 5 |
Millennium Management
New York
|
-$163K |
GCVRZ Hedge Fund Activity: Q1 2015 in Review
115 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2015, worth a combined $74M — down 19% from $91.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GCVRZ and 7 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 14 added.
The largest buyer was Elliott Management, opening a new position worth an estimated $6.02M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $6.22M sold.
- 115 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2015, down from 118 in Q4 2014.
- Funds reported $74M of Sanofi Contingent Value Rights stock for Q1 2015, down 19% quarter-over-quarter.
- 7 funds opened new Sanofi Contingent Value Rights positions in Q1 2015 and 8 closed out, a net change of -1 holder.
- The largest Sanofi Contingent Value Rights buyer in Q1 2015 was Elliott Management, an estimated $6.02M added.
- The largest Sanofi Contingent Value Rights seller in Q1 2015 was Sphera Funds Management, an estimated $6.22M sold.
Based on aggregated 13F filings for Q1 2015.